[Convulsions in mice after administration of a new aminolactone (FK-3)].
Vamvakidès
A
A
D000818:Animals; D004336:Drug Antagonism; D005998:Glycine / Q000378:metabolism; D007783:Lactones / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012640:Seizures / Q000139:chemically induced*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D007783:Lactones; D005680:gamma-Aminobutyric Acid; C058307:3-diethylaminomethyl-3,3-diphenyl-2-dihydrofuranone; D005998:Glycine
Etude des convulsions chez la souris après administration d'une nouvelle aminolactone (FK-3).